一线用药EGFR—TKIs与化疗治疗非选择型NSCLC效果的Meta分析(4)
[4] Crino L,Cappuzzo F,Zatloukal P,et al. Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE):a randomized,phase II study [J]. J Clin Oncol,2008,26(26):4253-4260.[5] Chen YM,Tsai CM,Fan WC,et al. Phase Ⅱ randomized trial of erlotinib or vinorelbine in chemonaive,advanced,non-small cell lung cancer patients aged 70 years or older [J]. J Thorac Oncol ......
您现在查看是摘要页,全文长 3768 字符。